Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study
Sign Up to like & getrecommendations! Published in 2017 at "Neurotherapeutics"
DOI: 10.1007/s13311-017-0512-4
Abstract: Whether antiplatelet agents have a preventive effect on cognitive function remains unknown. We examined the potential association between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk… read more here.
Keywords: cilostazol; cilostazol use; risk dementia; dementia ... See more keywords